Semaglutide and tirzepatide are prescription medications that may be used as part of a medical weight management plan when clinically appropriate. If a compounded formulation is prescribed, it is prepared by a licensed pharmacy based on an individual patient’s prescription and clinical needs. Your provider will review your medical history, current medications, and eligibility during an evaluation and will discuss potential risks, alternatives, and expected follow-up.

These prescription medications are generally understood to work through pathways related to appetite regulation and satiety. Individual response varies. Your provider will determine whether treatment is appropriate based on your health status and will provide individualized guidance on dosing, monitoring, and follow-up care.

Results vary from person to person. Weight changes depend on multiple factors, including individual health status, adherence to the care plan, nutrition, activity, and duration of treatment. Your provider will discuss realistic expectations and how progress may be monitored over time.

Semaglutida y Tirzepatida se presentan en forma de solución líquida estéril que se administra mediante inyección subcutánea una vez por semana.